Harvard
Reinhard, H
, Jacobsen, PK, Lajer, MS
, Tarnow, L, Bording Astrup, AS, Kim, WY, Pedersen, N, Billestrup, N, Mandrup-Poulsen, T, Parving, H-H
& Rossing, P 2011, '
Endothelial progenitor cells in long-standing asymptomatic type 1 diabetic patients with or without diabetic nephropathy',
Nephron Clinical Practice, bind 118, nr. 3, s. c309-14.
https://doi.org/10.1159/000322667
APA
Reinhard, H.
, Jacobsen, P. K., Lajer, M. S.
, Tarnow, L., Bording Astrup, A. S., Kim, W. Y., Pedersen, N., Billestrup, N., Mandrup-Poulsen, T., Parving, H-H.
, & Rossing, P. (2011).
Endothelial progenitor cells in long-standing asymptomatic type 1 diabetic patients with or without diabetic nephropathy.
Nephron Clinical Practice,
118(3), c309-14.
https://doi.org/10.1159/000322667
CBE
Reinhard H
, Jacobsen PK, Lajer MS
, Tarnow L, Bording Astrup AS, Kim WY, Pedersen N, Billestrup N, Mandrup-Poulsen T, Parving H-H
, Rossing P. 2011.
Endothelial progenitor cells in long-standing asymptomatic type 1 diabetic patients with or without diabetic nephropathy.
Nephron Clinical Practice. 118(3):c309-14.
https://doi.org/10.1159/000322667
MLA
Vancouver
Author
Reinhard, Henrik
; Jacobsen, Peter Karl ; Lajer, Maria Stenkil
; Tarnow, Lise ; Bording Astrup, Anne Sofie ; Kim, Won Yong ; Pedersen, Nadja ; Billestrup, Nils ; Mandrup-Poulsen, Thomas ; Parving, Hans-Henrik
; Rossing, Peter. /
Endothelial progenitor cells in long-standing asymptomatic type 1 diabetic patients with or without diabetic nephropathy. I:
Nephron Clinical Practice. 2011 ; Bind 118, Nr. 3. s. c309-14.
Bibtex
@article{9eabc265c1484ec2957baee6b930ddd8,
title = "Endothelial progenitor cells in long-standing asymptomatic type 1 diabetic patients with or without diabetic nephropathy",
abstract = "A decrease in the number and dysfunction of endothelial progenitor cells (EPC) may increase the risk for progression of cardiovascular disease (CVD) in type 1 diabetic patients with diabetic nephropathy (DN). Our aim was to evaluate EPC numbers in asymptomatic CVD type 1 diabetic patients with or without DN and to study the effect of CVD and medication on EPC numbers.",
keywords = "Adult, Anticholesteremic Agents, Calcium Channel Blockers, Cardiovascular Diseases, Cell Count, Cross-Sectional Studies, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Endothelial Cells, Female, Humans, Male, Mesenchymal Stem Cells, Middle Aged, Risk Factors, Simvastatin",
author = "Henrik Reinhard and Jacobsen, {Peter Karl} and Lajer, {Maria Stenkil} and Lise Tarnow and {Bording Astrup}, {Anne Sofie} and Kim, {Won Yong} and Nadja Pedersen and Nils Billestrup and Thomas Mandrup-Poulsen and Hans-Henrik Parving and Peter Rossing",
note = "Copyright {\textcopyright} 2011 S. Karger AG, Basel.",
year = "2011",
doi = "10.1159/000322667",
language = "English",
volume = "118",
pages = "c309--14",
journal = "Experimental Nephrology",
issn = "0028-2766",
publisher = "S./Karger AG",
number = "3",
}
RIS
TY - JOUR
T1 - Endothelial progenitor cells in long-standing asymptomatic type 1 diabetic patients with or without diabetic nephropathy
AU - Reinhard, Henrik
AU - Jacobsen, Peter Karl
AU - Lajer, Maria Stenkil
AU - Tarnow, Lise
AU - Bording Astrup, Anne Sofie
AU - Kim, Won Yong
AU - Pedersen, Nadja
AU - Billestrup, Nils
AU - Mandrup-Poulsen, Thomas
AU - Parving, Hans-Henrik
AU - Rossing, Peter
N1 - Copyright © 2011 S. Karger AG, Basel.
PY - 2011
Y1 - 2011
N2 - A decrease in the number and dysfunction of endothelial progenitor cells (EPC) may increase the risk for progression of cardiovascular disease (CVD) in type 1 diabetic patients with diabetic nephropathy (DN). Our aim was to evaluate EPC numbers in asymptomatic CVD type 1 diabetic patients with or without DN and to study the effect of CVD and medication on EPC numbers.
AB - A decrease in the number and dysfunction of endothelial progenitor cells (EPC) may increase the risk for progression of cardiovascular disease (CVD) in type 1 diabetic patients with diabetic nephropathy (DN). Our aim was to evaluate EPC numbers in asymptomatic CVD type 1 diabetic patients with or without DN and to study the effect of CVD and medication on EPC numbers.
KW - Adult
KW - Anticholesteremic Agents
KW - Calcium Channel Blockers
KW - Cardiovascular Diseases
KW - Cell Count
KW - Cross-Sectional Studies
KW - Diabetes Mellitus, Type 1
KW - Diabetic Nephropathies
KW - Endothelial Cells
KW - Female
KW - Humans
KW - Male
KW - Mesenchymal Stem Cells
KW - Middle Aged
KW - Risk Factors
KW - Simvastatin
U2 - 10.1159/000322667
DO - 10.1159/000322667
M3 - Journal article
C2 - 21252582
VL - 118
SP - c309-14
JO - Experimental Nephrology
JF - Experimental Nephrology
SN - 0028-2766
IS - 3
ER -